HEALTH
Gilead’s coronavirus drug will cost $2,340 — which sounds expensive, but here’s why it’s not
HEALTH

Gilead’s coronavirus drug will cost $2,340 — which sounds expensive, but here’s why it’s not

Published: June 29, 2020  |  4 min read, 724 words
WRITTEN BY
Your review will affect the following:
Gilead Sciences Inc.’s COVID-19 drug remdesivir will cost much less than Wall Street analysts had predicted in a move that likely points to a more measured, responsible approach to the pricing of treatments and vaccines during the pandemic.Shares of Gileadgained 0.9% in trading on Monday following the made before the market opened. U.S. health officials separately said Monday morning that the government of remdesivir for Americans through September, to be purchased by hospitals.The cost of remdesivir for a 5-day course of treatment is $2,340 in all developed countries, a price tag that is... READ MORE
CRITIC
N/A
N/Ano rating
Critic Reviews: N/A
We calculate ratings after a minimum of three reviews.
USER
marketwatch.com
Outlet Rating
marketwatch.com
img-trusted
88%
User Reviews: N/A
TOP REVIEWS
There are no reviews yet.

CRITIC REVIEWS

There don't seem to be any reviews yet.

PUBLIC REVIEWS

There don't seem to be any reviews yet.